Modifying disability in progressive multiple sclerosis

Modifying disability in progressive multiple sclerosis

Εμφάνιση άλλων εκδόσεων (1)

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Palace, J, Robertson, N
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	Lancet 2014

Παρόμοια τεκμήρια

Modifying disability in progressive multiple sclerosis.
ανά: Palace, J, κ.ά.
Έκδοση: (2014)

Brain reserve and physical disability in secondary progressive multiple sclerosis
ανά: Nevin John, κ.ά.
Έκδοση: (2024-09-01)

Effect of smoking on disability progression in patients with multiple sclerosis
ανά: Tuncay Gündüz, κ.ά.
Έκδοση: (2018-10-01)

The multiple sclerosis monitoring study: Progress to date
ανά: Cooper, C, κ.ά.
Έκδοση: (2004)

Chronic lesion activity and disability progression in secondary progressive multiple sclerosis
ανά: Gavin Giovannoni, κ.ά.
Έκδοση: (2022-06-01)

EVIDENCE OF SUBCORTICAL ATROPHY IN PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS
ανά: Arun, T, κ.ά.
Έκδοση: (2009)

The Effect of Disease Modifying Therapies on Disability Progression in Multiple Sclerosis: A Systematic Overview of Meta-Analyses
ανά: Suzi B. Claflin, κ.ά.
Έκδοση: (2019-01-01)

Radiotherapy Improves the Disability in Patients with Secondary Progressive Multiple Sclerosis
ανά: Hossein-Ali Ebrahimi, κ.ά.
Έκδοση: (2023-08-01)

Making the diagnosis of multiple sclerosis.
ανά: Palace, J
Έκδοση: (2001)

Serum glial fibrillary acidic protein and disability progression in progressive multiple sclerosis
ανά: Ahmed Abdelhak, κ.ά.
Έκδοση: (2024-02-01)

Fibrin(ogen) and neurodegeneration in the progressive multiple sclerosis cortex
ανά: Yates, R, κ.ά.
Έκδοση: (2017)

Relating neocortical pathology to disability progression in multiple sclerosis using MRI.
ανά: Chen, J, κ.ά.
Έκδοση: (2004)

Patient choice and adherence with disease-modifying therapy in multiple sclerosis
ανά: Burke, G, κ.ά.
Έκδοση: (2004)

New and old treatments for multiple sclerosis.
ανά: Palace, J
Έκδοση: (1998)

White matter and lesion T1 relaxation times increase in parallel and correlate with disability in multiple sclerosis.
ανά: Parry, A, κ.ά.
Έκδοση: (2002)

Multiple sclerosis patients in Japan appear to have less disability compared to the UK
ανά: Kumar, G, κ.ά.
Έκδοση: (2013)

Thalamic Atrophy Predicts 5-Year Disability Progression in Multiple Sclerosis
ανά: Katariina Hänninen, κ.ά.
Έκδοση: (2020-07-01)

The UK Multiple Sclerosis database.
ανά: Palace, J, κ.ά.
Έκδοση: (1999)

Genetic Factors Associated with Risk and Disability Progression of Multiple Sclerosis in Slovak Population
ανά: Hanysova Sandra, κ.ά.
Έκδοση: (2017-08-01)

Estimating typical multiple sclerosis disability progression speed from clinical observations.
ανά: Murray G Brown, κ.ά.
Έκδοση: (2014-01-01)

Guidelines for differential diagnosis of suspected multiple sclerosis.
ανά: Palace, J
Έκδοση: (2009)

New treatments and azathioprine in multiple sclerosis.
ανά: Palace, J, κ.ά.
Έκδοση: (1997)

Early clinical predictors of disease progression in relapsing-remitting multiple sclerosis: the Oxford UK cohort
ανά: Wakerley, B, κ.ά.
Έκδοση: (2011)

DISABILITY PROGRESSION IN PATIENTS WITH RELAPSING REMITTING MULTIPLE SCLEROSIS (RRMS) WHO EXPERIENCE DISEASE ACTIVITY DESPITE PREVIOUS DISEASE MODIFYING THERAPY
ανά: Hettle, R, κ.ά.
Έκδοση: (2011)

Multiple sclerosis associated with Leber's Hereditary Optic Neuropathy.
ανά: Palace, J
Έκδοση: (2009)

Age and disability accumulation in multiple sclerosis.
ανά: Scalfari, A, κ.ά.
Έκδοση: (2011)

Impairment, disability and fatigue in multiple sclerosis
ανά: Shahnaz Shahrbanian, κ.ά.
Έκδοση: (2018-05-01)

The UK long-term cost-effectiveness study of disease-modifying therapies in multiple sclerosis: lessons from tire first analysis
ανά: Palace, J, κ.ά.
Έκδοση: (2008)

Leptomeningeal Contrast Enhancement Is Associated with Disability Progression and Grey Matter Atrophy in Multiple Sclerosis
ανά: Gleb Makshakov, κ.ά.
Έκδοση: (2017-01-01)

The Relationship between Gray Matter Quantitative MRI and Disability in Secondary Progressive Multiple Sclerosis.
ανά: René-Maxime Gracien, κ.ά.
Έκδοση: (2016-01-01)

Estimating individual treatment effect on disability progression in multiple sclerosis using deep learning
ανά: Jean-Pierre R. Falet, κ.ά.
Έκδοση: (2022-09-01)

Impact of natalizumab on ambulatory improvement in secondary progressive and disabled relapsing-remitting multiple sclerosis.
ανά: Diego Cadavid, κ.ά.
Έκδοση: (2013-01-01)

Short-term disability progression in two multiethnic multiple sclerosis centers in the treatment era
ανά: Ilya Kister, κ.ά.
Έκδοση: (2018-09-01)

Association Between Sunlight Exposure and Vitamin D Intake and Multiple Sclerosis Disability and Progression
ανά: Emad Fayyazi, κ.ά.
Έκδοση: (2018-08-01)

Progressive multifocal leukoencephalopathy as a complication of disease-modifying treatment of multiple sclerosis
ανά: Maria N. Zakharova, κ.ά.
Έκδοση: (2018-12-01)

Multiple sclerosis lesions: insights from imaging techniques.
ανά: Tomassini, V, κ.ά.
Έκδοση: (2009)

Modafinil for multiple sclerosis fatigue: does it work?
ανά: Littleton, E, κ.ά.
Έκδοση: (2010)

How patients with multiple sclerosis acquire disability
ανά: Lublin, FD, κ.ά.
Έκδοση: (2022)

An approach to the identification of targets of autoantibodies in multiple sclerosis
ανά: Littleton, E, κ.ά.
Έκδοση: (2004)

Brain atrophy and lesion load predict long term disability in multiple sclerosis.
ανά: Popescu, V, κ.ά.
Έκδοση: (2013)